Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven I Aronin

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 1, 2022
Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018-2020Steven I Aronin, Vikas Gupta, Michael W Dunne, et al.
BMC Infectious Diseases|March 1, 2022
A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020Michael W Dunne, Steven I Aronin, Kalvin C Yu, et al.
Journal of Global Antimicrobial Resistance|June 24, 2025
In vitro activity of sulopenem and comparator agents against US Enterobacterales clinical isolates collected during the SENTRY antimicrobial surveillance program in 2023Steven I Aronin, Michael D Huband, Holly Becker, et al.
NEJM Evidence|June 24, 2025
Sulopenem versus Amoxicillin/Clavulanate for the Treatment of Uncomplicated Urinary Tract InfectionSailaja Puttagunta, Steven I Aronin, Jayanti Gupta, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2023
In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance ProgramJoshua M Maher, Michael D Huband, Christopher G Blankers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2022
Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized TrialMichael W Dunne, Steven I Aronin, Anita F Das, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 4, 2024
A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intra-abdominal infectionsMichael W Dunne, Steven I Aronin, Anita F Das, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2022
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized TrialMichael W Dunne, Steven I Aronin, Anita F Das, et al.
Microbiology Spectrum|February 5, 2025
Characterization of sulopenem antimicrobial activity using <i>in vitro</i> time-kill kinetics, synergy, post-antibiotic effect, and sub-inhibitory MIC effect methods against <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> isolatesJoshua M Maher, Michael D Huband, Jill M Lindley, et al.
Idcases|February 4, 2016
A depiction of imported malaria in ConnecticutDavid Chia, Jorge O Moreno, Steven I Aronin, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 1, 2022
Regional Differences in Antibiotic-resistant Enterobacterales Urine Isolates in the United States: 2018-2020Steven I Aronin, Vikas Gupta, Michael W Dunne, et al.
BMC Infectious Diseases|March 1, 2022
A multicenter analysis of trends in resistance in urinary Enterobacterales isolates from ambulatory patients in the United States: 2011-2020Michael W Dunne, Steven I Aronin, Kalvin C Yu, et al.
Journal of Global Antimicrobial Resistance|June 24, 2025
In vitro activity of sulopenem and comparator agents against US Enterobacterales clinical isolates collected during the SENTRY antimicrobial surveillance program in 2023Steven I Aronin, Michael D Huband, Holly Becker, et al.
NEJM Evidence|June 24, 2025
Sulopenem versus Amoxicillin/Clavulanate for the Treatment of Uncomplicated Urinary Tract InfectionSailaja Puttagunta, Steven I Aronin, Jayanti Gupta, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2023
In vitro activity of sulopenem and comparator agents against Enterobacterales and anaerobic clinical isolates collected during the SENTRY Antimicrobial Surveillance ProgramJoshua M Maher, Michael D Huband, Christopher G Blankers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2022
Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized TrialMichael W Dunne, Steven I Aronin, Anita F Das, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 4, 2024
A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intra-abdominal infectionsMichael W Dunne, Steven I Aronin, Anita F Das, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2022
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized TrialMichael W Dunne, Steven I Aronin, Anita F Das, et al.
Microbiology Spectrum|February 5, 2025
Characterization of sulopenem antimicrobial activity using <i>in vitro</i> time-kill kinetics, synergy, post-antibiotic effect, and sub-inhibitory MIC effect methods against <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> isolatesJoshua M Maher, Michael D Huband, Jill M Lindley, et al.
Idcases|February 4, 2016
A depiction of imported malaria in ConnecticutDavid Chia, Jorge O Moreno, Steven I Aronin, et al.
Pageof 3